重型创伤性脑损伤患者早发性呼吸机相关性肺炎:发生率、危险因素及其对脑氧合与预后的影响
该回顾性观察研究纳入175例重型TBI插管患者,EOVAP定义为临床肺部感染评分>6并经有创方法确认,发生率为60.6%(47.4/1000通气日)。治疗性低温(OR 3.4)、胸部AIS≥3(OR 2.4)和胃误吸(OR 5.2)是EOVAP的显著危险因素,预防性抗生素为保护因素(OR 0.3)。EOVAP期间PbtO2较低(23.5 vs 26.4 mmHg,p<0.0001),脑缺氧发作更多(32% vs 27%,p=0.03)。校正混杂因素后,EOVAP与1年不良神经功能预后独立相关(OR 2.71;95%CI 1.01-7.25)。作者认为应采取一切可用预防措施预防该人群EOVAP。
要点
- 重型TBI插管患者EOVAP发生率60.6%(47.4/1000通气日),1年不良预后OR 2.71(95%CI 1.01-7.25)。
- 治疗性低温(OR 3.4;95%CI 1.2-10.0)、胸部AIS≥3(OR 2.4;95%CI 1.1-5.7)、胃误吸(OR 5.2;95%CI 1.7-15.9)是EOVAP显著危险因素。
- 预防性抗生素使用是EOVAP的保护因素(OR 0.3;95%CI 0.1-0.8)。
- EOVAP期间PbtO2较低(23.5 vs 26.4 mmHg,p<0.0001),脑缺氧发作更多(32% vs 27%,p=0.03)。
- 作者认为应采取一切可用预防措施预防该人群EOVAP。
适用人群与场景
- 重型创伤性脑损伤(TBI)且接受插管的患者,收治于创伤中心ICU。
诊断标准与关键阈值
- EOVAP定义为临床肺部感染评分>6,并经有创方法确认。
研究设计与关键结果
- 回顾性观察研究,纳入175例重型TBI插管患者,研究期7年;EOVAP发生率60.6%(47.4/1000通气日)。
- EOVAP显著危险因素:治疗性低温(OR 3.4;95%CI 1.2-10.0)、胸部AIS评分≥3(OR 2.4;95%CI 1.1-5.7)、胃误吸(OR 5.2;95%CI 1.7-15.9)。
- 预防性抗生素使用是EOVAP的保护因素(OR 0.3;95%CI 0.1-0.8)。
- EOVAP期间PbtO2较低:23.5 vs 26.4 mmHg(p<0.0001);脑缺氧发作更多:32% vs 27%(p=0.03)。
- 校正混杂因素后,EOVAP与1年随访不良神经功能预后独立相关(OR 2.71;95%CI 1.01-7.25)。
证据类型、等级与局限
- 证据类型:回顾性观察研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,应采取一切可用预防措施预防该人群EOVAP。
- 原文未据此给出其他推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Early-onset ventilator-associated pneumonia (EOVAP) occurs frequently in severe traumatic brain-injured patients, but potential consequences on cerebral oxygenation and outcome have been poorly studied. The objective of this study was to describe the incidence, risk factors for, and consequences on cerebral oxygenation and outcome of EOVAP after severe traumatic brain injury (TBI).
METHODS: We conducted a retrospective, observational study including all intubated TBI admitted in the trauma center. An EOVAP was defined as a clinical pulmonary infection score >6, and then confirmed by an invasive method. Patient characteristics, computed tomography (CT) scan results, and outcome were extracted from a prospective register of all intubated TBI admitted in the intensive care unit (ICU). Data concerning the cerebral oxygenation monitoring by PbtO2 and characteristics of EOVAP were retrieved from patient files. Multivariate logistic regression models were developed to determine the risk factors of EOVAP and to describe the factors independently associated with poor outcome at 1-year follow-up.
RESULTS: During 7 years, 175 patients with severe TBI were included. The overall incidence of EOVAP was 60.6% (47.4/1000 days of ventilation). Significant risk factors of EOVAP were: therapeutic hypothermia (OR 3.4; 95% CI [1.2-10.0]), thoracic AIS score ≥3 (OR 2.4; 95% CI [1.1-5.7]), and gastric aspiration (OR 5.2, 95% CI [1.7-15.9]). Prophylactic antibiotics administration was a protective factor against EOVAP (OR 0.3, 95% CI [0.1-0.8]). EOVAP had negative consequences on cerebral oxygenation. The PbtO2 was lower during EOVAP: 23.5 versus 26.4 mmHg (p <0.0001), and there were more brain hypoxia episodes: 32 versus 27% (p = 0.03). Finally, after adjusting for confounders, an EOVAP was an independent factor associated with unfavorable neurologic functional outcome at the 1-year follow-up (OR 2.71; 95% CI [1.01-7.25]).
CONCLUSIONS: EOVAP is frequent after a severe TBI (overall rate: 61%), with therapeutic hypothermia, severe thoracic lesion, and gastric aspiration as main risk factors. EOVAP had a negative impact on cerebral oxygenation measured by PbtO2 and was independently associated with unfavorable outcome at 1-year follow-up. This suggests that all precautions available should be taken to prevent EOVAP in this population.
参考来源
- Esnault P, Nguyen C, Bordes J, et al. Early-Onset Ventilator-Associated Pneumonia in Patients with Severe Traumatic Brain Injury: Incidence, Risk Factors, and Consequences in Cerebral Oxygenation and Outcome. Neurocrit Care. 2017. PMID: 28432539. doi:10.1007/s12028-017-0397-4
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。